User profiles for "author:Christophe Rosty"

Christophe Rosty

The University of Queensland, The University of Melbourne
Verified email at uq.edu.au
Cited by 14387

[HTML][HTML] Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical management

C Rosty, DG Hewett, IS Brown, BA Leggett… - Journal of …, 2013 - Springer
Approximately 30% of colorectal carcinomas develop via the serrated neoplasia pathway
characterized by widespread DNA methylation and frequent BRAF mutation. Serrated …

Early detection of pancreatic carcinoma

C Rosty, M Goggins - Hematology/Oncology Clinics, 2002 - hemonc.theclinics.com
Pancreatic cancer is the fourth leading cause of cancer death in men and women;
approximately 28,000 patients are diagnosed with pancreatic cancer and approximately …

Rising incidence of early‐onset colorectal cancer in A ustralia over two decades: Report and review

JP Young, AK Win, C Rosty, I Flight… - Journal of …, 2015 - Wiley Online Library
The average age at diagnosis for colorectal cancer (CRC) in A ustralia is 69, and the age‐
specific incidence rises rapidly after age 50 years. The incidence has stabilized or is …

Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of …

P Argani, C Iacobuzio-Donahue, B Ryu, C Rosty… - Clinical cancer …, 2001 - AACR
Purpose: Effective new markers of pancreatic carcinoma are urgently needed. In a previous
analysis of gene expression in pancreatic adenocarcinoma using serial analysis of gene …

Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays

CA Iacobuzio-Donahue, A Maitra, M Olsen… - The American journal of …, 2003 - Elsevier
Pancreatic cancer is the fifth leading cause of cancer death in the United States. We used
cDNA microarrays to analyze global gene expression patterns in 14 pancreatic cancer cell …

Association between molecular subtypes of colorectal cancer and patient survival

AI Phipps, PJ Limburg, JA Baron, AN Burnett-Hartman… - Gastroenterology, 2015 - Elsevier
Background and Aims Colorectal cancer (CRC) is a heterogeneous disease that can
develop via several pathways. Different CRC subtypes, identified based on tumor markers …

Prevalence and penetrance of major genes and polygenes for colorectal cancer

AK Win, MA Jenkins, JG Dowty, AC Antoniou… - … Biomarkers & Prevention, 2017 - AACR
Background: Although high-risk mutations in identified major susceptibility genes (DNA
mismatch repair genes and MUTYH) account for some familial aggregation of colorectal …

The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma

M Tascilar, HG Skinner, C Rosty, T Sohn… - Clinical Cancer …, 2001 - AACR
Purpose: SMAD4 (also called Dpc4) is a tumor suppressor in the TGF-β signaling pathway
that is genetically inactivated in∼ 55% of all pancreatic adenocarcinomas. We investigated …

Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma

P Argani, C Rosty, RE Reiter, RE Wilentz… - Cancer research, 2001 - AACR
Serial analysis of gene expression (SAGE) can be used to quantify gene expression in
human tissues. Comparison of gene expression levels in neoplastic tissues with those seen …

Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip …

C Rosty, L Christa, S Kuzdzal, WM Baldwin… - Cancer research, 2002 - AACR
New biomarkers of pancreatic adenocarcinoma are needed to improve the early detection of
this deadly disease. We performed surface enhanced laser desorption ionization (SELDI) …